Peptide

Icatibant (Firazyr)

FDA-approved product existsImmune & gut
Not yet scored

BioHarmony verdict

Awaiting review

No BioHarmony report yet. It is queued for review; until then, rely on the status and sources below.

What is Icatibant (Firazyr)?

FDA-approved icatibant is marketed as Firazyr for treatment of acute hereditary angioedema attacks in adults 18 years and older.

Dosing as published

Approved labelFIRAZYR prescribing information for acute hereditary-angioedema attacks
PopulationAdults covered by the approved FIRAZYR indication
Dose30 mg; if response is inadequate or symptoms recur, additional 30 mg injections may be given at intervals of at least 6 hours, with no more than 3 injections in 24 hours.
RouteSubcutaneous injection in the abdominal area
FrequencyPer acute attack, with label-defined repeat-dose limits
DurationSingle-attack use
PreparationReady-to-use 30 mg/3 mL single-dose prefilled syringe; no reconstitution.
Source: Dosage and Administration sections 2.1-2.2; Dosage Forms and Strengths section 3

More reported protocols

Members

Members can compare additional reported doses, schedules, and preparation notes.

Trust & sourcing

US approvalFDA-approved product exists
CompoundingFDA-approved product exists; compounded copies are not FDA approved
Last checked2026-07-13
Next review2026-10-11

Primary sources

  1. 7.5/10BPC-157Strong recommendRecoveryNot FDA approvedBPC-157 is a 15-amino-acid gastric peptide fragment with consistent preclinical repair data, including a 2025 sports-medicine systematic review of 36 studies with 35…
  2. 7.5/10TB-500 (Thymosin Beta-4 Fragment)Strong recommendRecoveryNot FDA approvedTB-500 is a synthetic LKKTETQ fragment marketed for soft-tissue repair, but most human evidence is on full-length topical thymosin beta-4: Sosne 2023 reported corneal…
  3. 7.4/10GHK-Cu (Copper Peptide)Strong recommendRecoveryNot FDA approvedGHK-Cu is a human copper-binding tripeptide with the best evidence for topical skin repair and wound healing, including Mulder 1994 diabetic ulcer data showing 98.5%…
  4. 7.3/10Thymosin Alpha-1Strong recommendRecoveryNot FDA approvedFDA identifies immunogenicity and peptide-impurity concerns for compounded thymosin alpha-1 and says available safety information is inadequate.

Free guide

The Ultimate Peptides Guide

Spot stronger candidates, weak evidence, and seller red flags before you buy.

Free. Includes evidence and regulatory updates. Unsubscribe anytime.